- Home
- ANNX vs API Comparison
ANNX vs API Comparison
Compare ANNX & API Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANNX
- API
- Stock Information
- Founded
- ANNX 2011
- API 2013
- Country
- ANNX United States
- API United States
- Employees
- ANNX N/A
- API N/A
- Industry
- ANNX Biotechnology: Pharmaceutical Preparations
- API Computer Software: Prepackaged Software
- Sector
- ANNX Health Care
- API Technology
- Exchange
- ANNX Nasdaq
- API Nasdaq
- Market Cap
- ANNX 334.1M
- API 315.7M
- IPO Year
- ANNX 2020
- API 2020
- Fundamental
- Price
- ANNX $2.92
- API $3.49
- Analyst Decision
- ANNX Strong Buy
- API Strong Buy
- Analyst Count
- ANNX 4
- API 1
- Target Price
- ANNX $13.00
- API $6.00
- AVG Volume (30 Days)
- ANNX 1.9M
- API 313.6K
- Earning Date
- ANNX 11-10-2025
- API 11-19-2025
- Dividend Yield
- ANNX N/A
- API N/A
- EPS Growth
- ANNX N/A
- API N/A
- EPS
- ANNX N/A
- API N/A
- Revenue
- ANNX N/A
- API $133,554,000.00
- Revenue This Year
- ANNX N/A
- API $7.20
- Revenue Next Year
- ANNX N/A
- API $11.26
- P/E Ratio
- ANNX N/A
- API N/A
- Revenue Growth
- ANNX N/A
- API N/A
- 52 Week Low
- ANNX $1.29
- API $2.53
- 52 Week High
- ANNX $6.93
- API $6.99
- Technical
- Relative Strength Index (RSI)
- ANNX 45.55
- API 45.45
- Support Level
- ANNX $2.66
- API $3.45
- Resistance Level
- ANNX $3.03
- API $3.76
- Average True Range (ATR)
- ANNX 0.24
- API 0.12
- MACD
- ANNX -0.04
- API 0.01
- Stochastic Oscillator
- ANNX 26.98
- API 42.71
About ANNX Annexon Inc.
Annexon Inc is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain, and eye. Its pipeline is based on its platform technology addressing well-researched classical complement-mediated autoimmune and neurodegenerative disease processes, both of which are triggered by aberrant activation of C1q. Its pipeline of product candidates is designed to block the activity of C1q and the entire classical complement pathway in a broad set of complement-mediated diseases. Its product candidates are ANX005, for autoimmune & neurodegenerative disorders; ANX007, for neurodegenerative ophthalmic disorders; ANX1502 for Oral small molecule; and ANX009, for systemic autoimmune diseases.
About API Agora Inc.
Agora Inc provides real-time communication solutions. The company offers real-time video calling, voice calling, live audio and video streaming, recording, and real-time messaging. It serves the gaming, retail, and education industries. The company operates in the People's Republic of China and the United States of America and the majority of its revenue is derived from the People's Republic of China.